An experimental COVID-19 therapy tablet, referred to as molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen on this undated handout picture launched by Merck & Co Inc and obtained by Reuters on October 26, 2021. Merck & Co Inc/Handout through REUTERS
MANILA, Oct 27 (Reuters) – The Philippines will obtain 300,000 programs of Merck & Co’s (MRK.N)COVID-19 antiviral drugnext month, licensed importers and distributors stated on Wednesday, as Asian nations race to get early entry to the experimental tablet amid giant demand.
Singapore and Malaysia have signed offers to purchase the drug, Molnupiravir, whereas Indonesia is finalising a purchase agreement, amongst a slew of orders after data from interim clinical trials confirmed the tablets may halve the chance of hospitalisation or dying for sufferers vulnerable to extreme COVID-19. read more
“Molnupiravir can now be accessed by our countrymen upon being prescribed for such use by their respective physicians,” Monaliza Salian, president of MedEthix, a Philippine healthcare merchandise importer, advised a information convention.
MedEthix will import 300,000 programs of Molnupiravir for COVID-19 sufferers in 4 hospitals, she added. The cargo would be the first batch of the drug to reach within the Philippines.
Every tablet is estimated to price 100 to 150 pesos ($1.97 to $2.96), stated Meneleo Hernandez, president of pharmaceutical agency JackPharma, which can distribute the drug regionally.
The Philippines has permitted the “compassionate use” of Molnupiravir for 31 hospitals, Meals and Drug Administration Chief Rolando Enrique Domingo advised Reuters on Wednesday.
Molnupiravir could be the world’s first oral antiviral remedy for COVID-19 if it will get regulatory approval.
The Philippines’ well being ministry on Wednesday reported 3,218 new COVID-19 instances, the bottom single-day tally in additional than 5 months. It has thus far absolutely inoculated roughly 26 million of its 110 million inhabitants.
With practically 2.77 million instances and greater than 42,300 deaths, the Philippines has the second highest variety of COVID-19 infections and deaths in Southeast Asia, after Indonesia.
$1 = 50.69 Philippine pesos)
Reporting by Neil Jerome Morales; Enhancing by James Pearson
Our Requirements: The Thomson Reuters Trust Principles.
0 Comments